Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|July 1, 2015
Discovery of non-competitive thrombin inhibitor derived from competitive tryptase inhibitor skeleton: Shift in molecular recognition resulted from skeletal conversion of carboxylate into phosphonateHiroshi Aoyama, Ryosuke Ijuin, Jun-ya Kato, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 26, 2023
Pentagamavunone-1 inhibits aggressive breast cancer cell proliferation through mitotic catastrophe and ROS-mediated activities: in vitro and in vivo studiesDhania Novitasari, Ikuko Nakamae, Riris Istighfari Jenie, et al.
Bioorganic & Medicinal Chemistry|June 19, 2014
Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug conceptKoichi Hasumi, Shuichiro Sato, Takahisa Saito, et al.
Pathology International|September 15, 2004
Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinomaAkiteru Goto, Toshiro Niki, Sachiko Moriyama, et al.
The Journal of Biological Chemistry|November 13, 2001
The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complexKiichiro Tomoda, Yukiko Kubota, Yukinobu Arata, et al.
Oncology Reports|January 14, 2004
Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancerAkihisa Fukumoto, Naoya Ikeda, Masayuki Sho, et al.
Advanced Pharmaceutical Bulletin|October 9, 2019
Cell Cycle Modulation of CHO-K1 Cells Under Genistein Treatment Correlates with Cells Senescence, Apoptosis and ROS Level but in a Dose-Dependent MannerRiris Istighfari Jenie, Nur Dina Amalina, Gagas Pradani Nur Ilmawati, et al.
Advances in Pharmacological and Pharmaceutical Sciences|December 4, 2024
The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro StudiesDhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato, et al.
Scientific Reports|October 18, 2019
Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescenceBeni Lestari, Ikuko Nakamae, Noriko Yoneda-Kato, et al.
Advanced Pharmaceutical Bulletin|August 8, 2022
Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological PropertiesRohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari, et al.
Pageof 6